PMID- 37062046
OWN - NLM
STAT- MEDLINE
DCOM- 20230602
LR  - 20240410
IS  - 1179-1896 (Electronic)
IS  - 1175-5652 (Linking)
VI  - 21
IP  - 4
DP  - 2023 Jul
TI  - Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring 
      System((R)) in Patients with Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus 
      with Multiple Daily Insulin Injections in Argentina.
PG  - 637-650
LID - 10.1007/s40258-023-00800-0 [doi]
AB  - OBJECTIVE: To estimate the budget impact of the potential coverage of FreeStyle 
      Libre Flash Continuous Glucose Monitoring System (FSL) for glycemia monitoring in 
      all type 1 diabetes mellitus (T1DM) patients and in those with type 2 diabetes 
      mellitus (T2DM) with multiple daily insulin injections, from the social security 
      and the private third-party payer's perspective in Argentina. METHODS: A budget 
      impact model was developed to estimate the cost difference between the 
      self-monitoring of blood glucose (standard of care) and FSL over 5 years. Input 
      parameters were retrieved from local literature complemented by expert opinion. 
      Health care costs were estimated by a micro-costing approach and reported in USD 
      as of April 2022 (1 USD = 113.34 Argentine pesos). One-way sensitivity and 
      scenario analyses were conducted. RESULTS: From a social security third-party 
      payer perspective, the incorporation of FSL was associated with net savings per 
      member per month (PMPM) of $0.026 (Year 1) to $0.097 (Year 5) and net savings 
      PMPM of $0.002 (Year 1) to $0.008 (Year 5) for T1DM and T2DM patients, 
      respectively. Similar findings are reported from the private third-party payer 
      perspective. The budget impact results were more sensitive to the acquisition 
      costs of the FSL and test strips. CONCLUSION: The potential coverage of FSL in 
      patients with T1DM and T2DM with multiple daily insulin injections could be 
      associated with small financial savings considering current technology 
      acquisition costs (FSL and test strips) for social security and the private 
      sector third-party payers in Argentina.
CI  - (c) 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
FAU - Palacios, Alfredo
AU  - Palacios A
AUID- ORCID: 0000-0001-7684-0880
AD  - Department of Health Technology Assessment and Health Economics, Institute for 
      Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina. 
      apalacios@iecs.org.ar.
AD  - Department of Economics, Universidad de Buenos Aires, Buenos Aires, Argentina. 
      apalacios@iecs.org.ar.
AD  - Centre for Health Economics (CHE), University of York, York, UK. 
      apalacios@iecs.org.ar.
FAU - Rodriguez-Cairoli, Federico
AU  - Rodriguez-Cairoli F
AUID- ORCID: 0000-0002-3029-4439
AD  - Department of Health Technology Assessment and Health Economics, Institute for 
      Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
FAU - Balan, Dario
AU  - Balan D
AD  - Department of Health Technology Assessment and Health Economics, Institute for 
      Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
FAU - Rojas-Roque, Carlos
AU  - Rojas-Roque C
AUID- ORCID: 0000-0002-1474-1550
AD  - Department of Health Technology Assessment and Health Economics, Institute for 
      Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
FAU - Moreno-Lopez, Carolina
AU  - Moreno-Lopez C
AD  - Department of Health Technology Assessment and Health Economics, Institute for 
      Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
FAU - Braun, Barbara
AU  - Braun B
AD  - Departamento de Clinica Medica y Diabetologia, Sanatorio de la Trinidad Palermo, 
      Buenos Aires, Argentina.
FAU - Augustovski, Federico
AU  - Augustovski F
AUID- ORCID: 0000-0002-2914-5022
AD  - Department of Health Technology Assessment and Health Economics, Institute for 
      Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
FAU - Pichon-Riviere, Andres
AU  - Pichon-Riviere A
AD  - Department of Health Technology Assessment and Health Economics, Institute for 
      Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
FAU - Bardach, Ariel
AU  - Bardach A
AUID- ORCID: 0000-0003-4437-0073
AD  - Department of Health Technology Assessment and Health Economics, Institute for 
      Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina.
AD  - Center for Research in Epidemiology and Public Health (CIESP), Buenos Aires, 
      Argentina.
LA  - eng
PT  - Journal Article
DEP - 20230416
PL  - New Zealand
TA  - Appl Health Econ Health Policy
JT  - Applied health economics and health policy
JID - 101150314
RN  - 0 (Insulin)
SB  - IM
MH  - Humans
MH  - *Continuous Glucose Monitoring/economics/methods
MH  - Argentina
MH  - *Diabetes Mellitus, Type 1/drug therapy
MH  - *Diabetes Mellitus, Type 2/drug therapy
MH  - *Insulin/administration & dosage/therapeutic use
MH  - *Health Care Costs
MH  - Costs and Cost Analysis
MH  - Insurance, Health, Reimbursement/economics
MH  - Private Sector
MH  - Social Security
EDAT- 2023/04/17 06:00
MHDA- 2023/06/02 06:42
CRDT- 2023/04/16 14:18
PHST- 2023/02/23 00:00 [accepted]
PHST- 2023/06/02 06:42 [medline]
PHST- 2023/04/17 06:00 [pubmed]
PHST- 2023/04/16 14:18 [entrez]
AID - 10.1007/s40258-023-00800-0 [pii]
AID - 10.1007/s40258-023-00800-0 [doi]
PST - ppublish
SO  - Appl Health Econ Health Policy. 2023 Jul;21(4):637-650. doi: 
      10.1007/s40258-023-00800-0. Epub 2023 Apr 16.